Kezar Life Sciences, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 BOLT
|
Bolt Biotherapeutics, Inc. | $0.58 | $29.02 M | -0.46 | 100 | $7.88 M |
 CGEM
|
Cullinan Oncology, Inc. | $12.52 | $1.29 B | -7.16 | 85 | $0 |
 DSGN
|
Design Therapeutics, Inc. | $5.61 | $217.51 M | -3.7 | 54 | $0 |
 FHTX
|
Foghorn Therapeutics Inc. | $7.84 | $332.53 M | -2.73 | 116 | $34.16 M |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $8.49 | $243.38 M | -1.59 | 133 | $0 |
 HOWL
|
Werewolf Therapeutics, Inc. | $1.90 | $151.66 M | -3.17 | 45 | $19.94 M |
 IKNA
|
Ikena Oncology, Inc. | $1.71 | $84.45 M | -1.11 | 14 | $9.16 M |
 IPSC
|
Century Therapeutics, Inc. | $1.20 | $244.54 M | -1.32 | 152 | $2.24 M |
 KROS
|
Keros Therapeutics, Inc. | $55.91 | $1.76 B | -9.45 | 160 | $151,000 |
 KYMR
|
Kymera Therapeutics, Inc. | $44.94 | $2.02 B | -13.13 | 184 | $78.59 M |
 LRMR
|
Larimar Therapeutics, Inc. | $6.16 | $611.84 M | -9.99 | 42 | $0 |
 LYEL
|
Lyell Immunopharma, Inc. | $0.94 | $619.50 M | -2.7 | 224 | $130,000 |
 MLYS
|
Mineralys Therapeutics, Inc. | $12.49 | $652.38 M | -6.03 | 28 | $0 |
 NGM
|
NGM Biopharmaceuticals, Inc. | $1.54 | $128.53 M | -0.89 | 138 | $4.42 M |
 NKTX
|
Nkarta, Inc. | $2.45 | $465.09 M | -2.81 | 159 | $0 |
 NRIX
|
Nurix Therapeutics, Inc. | $22.04 | $930.10 M | -5.89 | 284 | $76.99 M |
 RVMD
|
Revolution Medicines, Inc. | $56.71 | $6.66 B | -10.51 | 490 | $11.58 M |
 SRZN
|
Surrozen, Inc. | $9.15 | $35.47 M | -0.6 | 42 | $0 |
 STOK
|
Stoke Therapeutics, Inc. | $11.44 | $774.50 M | -6.14 | 110 | $8.78 M |
 STTK
|
Shattuck Labs, Inc. | $1.00 | $333.81 M | -3.64 | 75 | $1.66 M |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |